Emergent BioSolutions director receives new equity awards
Emergent BioSolutions director Neal Franklin Fowler received new equity awards as part of his annual board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Emergent BioSolutions director Neal Franklin Fowler received new equity awards as part of his annual board compensation. He was granted 25,344 restricted stock units, each representing one share of common stock that will vest the day before the one-year anniversary of the grant, if he remains on the board.
He also received stock options for 11,296 shares at an exercise price of $7.99 per share, vesting on the same schedule. After these awards, he directly holds 160,847 shares of common stock, plus the newly granted options. These are compensation grants, not open‑market purchases or sales.
Insider Trade Summary
Grant/Award: 36,640 shares
Grant/Award
2 txns
Insider
Fowler Neal Franklin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 11,296 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 25,344 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 11,296 contracts (Direct);
Common Stock — 160,847 shares (Direct)
Footnotes (3)
- F1. Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
- F2. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
- F3. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
Key Figures
RSU grant: 25,344 RSUs
Option grant size: 11,296 options
Option exercise price: $7.99 per share
+2 more
5 metrics
RSU grant
25,344 RSUs
Annual non-employee director grant for board and committee service
Option grant size
11,296 options
Stock options granted for board and committee service
Option exercise price
$7.99 per share
Exercise price for newly granted stock options
Shares held after grant
160,847 shares
Common stock directly held by Neal Fowler after the RSU grant
Underlying shares per option
1 share per option
Each option covers one share of common stock
Key Terms
restricted stock units ("RSUs"), Stock Incentive Plan, Annual Grant Vesting Date, Black-Scholes value, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Incentive Plan financial
"granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
Annual Grant Vesting Date financial
"The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date")"
Black-Scholes value financial
"dividing by the Black-Scholes value of a single option calculated as of the date of the grant"
stock options financial
"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Emergent BioSolutions (EBS) director Neal Fowler report?
Director Neal Fowler reported receiving equity compensation, not market trades. He was granted 25,344 restricted stock units and 11,296 stock options as part of his non-employee director pay for board and committee service, all subject to future vesting conditions tied to continued board membership.
How many Emergent BioSolutions (EBS) RSUs were granted to Neal Fowler and when do they vest?
Neal Fowler was granted 25,344 restricted stock units. Each RSU converts into one share of Emergent BioSolutions common stock. The entire grant is scheduled to vest on the day prior to the one-year anniversary of the grant date, assuming he remains on the company’s board through that date.
What are the terms of Neal Fowler’s new stock options at Emergent BioSolutions (EBS)?
Fowler received stock options for 11,296 shares of Emergent BioSolutions common stock at a $7.99 exercise price. These options were granted under the company’s Stock Incentive Plan and will vest on the same one-year schedule as the RSUs, conditional on continued board service.
How were the number of stock options for Emergent BioSolutions (EBS) director Neal Fowler determined?
The option grant size was calculated under the company’s Stock Incentive Plan. It was based on 25% of the total non-employee director compensation value, divided by the Black-Scholes value of a single option as of the grant date, yielding 11,296 options for Fowler.
Are Neal Fowler’s Emergent BioSolutions (EBS) equity awards tied to his continued board service?
Yes. Both the 25,344 restricted stock units and the 11,296 stock options vest on the day before the one-year anniversary of the grant date only if Neal Fowler remains a member of Emergent BioSolutions’ board of directors through that Annual Grant Vesting Date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates